HealthQuill Pharma
GSK Plc., a British global pharmaceutical company, announced the FDA had approved an oral drug to treat anaemia arising from chronic kidney disease in patients who have been on dialysis for four months.
Drugs Pharma

FDA expands approval of kidney cancer drug to earlier-stage patients

HQ Team June 16, 2026: The US Food and Drug Administration (FDA) has expanded approval of belzutifan, a first-in-class kidney cancer drug, to.

Read More
Bharat Biotech, an Indian maker of vaccines for infectious diseases, has rolled out the world's first nasal Covid-19 drops as a booster dose, according to a company statement.
Drugs Pharma

AI-designed universal vaccine against coronavirus passes human trial

HQ Team June 9, 2026: Researchers at the University of Cambridge and UK biotech firm DIOSynVax have designed a vaccine targeting the entire.

Read More
The death toll in the Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda climbed to 130 as the WHO stated the situation as “deeply disturbing.”
Drugs Health Pharma

Ebola outbreak deaths at 130, WHO says situation ‘deeply concerning’

The death toll in the Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda climbed to 130 as the WHO stated.

Read More
The WHO has declared an Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda as a public health emergency following the death of 80 people linked to the disease and stated the risk was high that it could spread to neighbouring nations
Drugs Health Pharma

WHO declares Ebola outbreak in Congo, Uganda, as a public health emergency

The WHO has declared an Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda as a public health emergency following the.

Read More
Cholera cases fell 17% month-on-month to 16,198 in 16 countries across three regions of the World Health Organization in March, according to a statement from the global health agency on April 30.
Climate Health Pharma

Global cholera cases decline 17% in March: Global health agency 

Cholera cases fell 17% month-on-month to 16,198 in 16 countries across three regions of the World Health Organization in March, according to a.

Read More
US FDA clears Abbott Laboratories' new software to clear heart blockages.
Health Medical Pharma

Abbott gets FDA nod for software to help doctors open blocked arteries

May 3, 2026: The US Food and Drug Administration has cleared Abbott Laboratories’ new artificial-intelligence-powered software for coronary imaging, enabling doctors to have.

Read More
Novartis AG will buy a US-based private biotech company, Excellergy, Inc, for $2 billion to expand its allergy portfolio.
Drugs Health Pharma

Novartis AG to acquire Exellergy for $2 billion, expand allergy portfolio

Novartis AG will buy a US-based private biotech company, Excellergy, Inc, for $2 billion to expand its allergy portfolio.

Read More
Merck & Co will buy Terns Pharmaceuticals, Inc., a clinical-stage oncology company, for $6.7 billion to pocket an investigational drug to treat a type of blood cancer, according to a statement.
Drugs Health Pharma

Merck to buy Terns for $6.7 billion as Keytruda drug patent loss looms

Merck & Co will buy Terns Pharmaceuticals, Inc., a clinical-stage oncology company, for $6.7 billion to pocket an investigational drug to treat a.

Read More
Novo Nordisk A/S and United Laboratories International Holdings Limited (TUL) mid-stage trials, held in China, helped in reducing average blood sugar levels by up to 2.16% in diabetic patients and trimmed weight by almost 10%, according to a statement.
Drugs Health Pharma

Novo, United’s trial drug cuts sugar levels by 2.16%, weight loss of 9.8%

HQ Team March 25, 2026: Novo Nordisk A/S and United Laboratories International Holdings Limited (TUL) mid-stage trials, held in China, helped in reducing.

Read More
Pfizer Inc. and France-based Valneva SE's investigational vaccine has shown 70% efficacy in preventing Lyme disease in individuals aged five and above.
Drugs Medical Pharma

Pfizer, Valneva’s experimental Lyme disease vaccine shows 70% efficacy

HQ Team March 25, 2026: Pfizer Inc. and France-based Valneva SE‘s investigational vaccine has shown 70% efficacy in preventing Lyme disease in individuals.

Read More